These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 17067182)

  • 1. Post-transplant diabetes mellitus: risk reduction strategies in the elderly.
    Duclos A; Flechner LM; Faiman C; Flechner SM
    Drugs Aging; 2006; 23(10):781-93. PubMed ID: 17067182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The importance of different immunosuppressive regimens in the development of posttransplant diabetes mellitus.
    Prokai A; Fekete A; Pasti K; Rusai K; Banki NF; Reusz G; Szabo AJ
    Pediatr Diabetes; 2012 Feb; 13(1):81-91. PubMed ID: 21595806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for and management of post-transplantation cardiovascular disease.
    Fellström B
    BioDrugs; 2001; 15(4):261-78. PubMed ID: 11437691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-Transplant Diabetes Mellitus: Causes, Treatment, and Impact on Outcomes.
    Shivaswamy V; Boerner B; Larsen J
    Endocr Rev; 2016 Feb; 37(1):37-61. PubMed ID: 26650437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-transplant diabetes mellitus. The role of immunosuppression.
    Jindal RM; Sidner RA; Milgrom ML
    Drug Saf; 1997 Apr; 16(4):242-57. PubMed ID: 9113492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Post-transplant diabetes mellitus: diagnosis and treatment].
    Campise M
    G Ital Nefrol; 2007; 24(6):547-57. PubMed ID: 18278758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An update review of post-transplant diabetes mellitus: Concept, risk factors, clinical implications and management.
    Kanbay M; Copur S; Topçu AU; Guldan M; Ozbek L; Gaipov A; Ferro C; Cozzolino M; Cherney DZI; Tuttle KR
    Diabetes Obes Metab; 2024 Jul; 26(7):2531-2545. PubMed ID: 38558257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk assessment and management of post-transplant diabetes mellitus.
    Han E; Kim MS; Kim YS; Kang ES
    Metabolism; 2016 Oct; 65(10):1559-69. PubMed ID: 27621191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin resistance in kidney allograft recipients treated with calcineurin inhibitors.
    Wyzgał J; Paczek L; Sańko-Resmer J; Ciszek M; Nowak M; Rowiński W; Szmidt J; Durlik M
    Ann Transplant; 2007; 12(2):26-9. PubMed ID: 18173063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-transplant diabetes mellitus: the last 10 years with tacrolimus.
    Bäckman LA
    Nephrol Dial Transplant; 2004 Dec; 19 Suppl 6():vi13-vi16. PubMed ID: 15575021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-transplantation diabetes in kidney transplant recipients: an update on management and prevention.
    Conte C; Secchi A
    Acta Diabetol; 2018 Aug; 55(8):763-779. PubMed ID: 29619563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of pre-transplant dialysis modality on post-transplant diabetes mellitus after kidney transplantation.
    Courivaud C; Ladrière M; Toupance O; Caillard S; Hurault de Ligny B; Ryckelynck JP; Moulin B; Rieu P; Frimat L; Chalopin JM; Chauvé S; Kazory A; Ducloux D
    Clin Transplant; 2011; 25(5):794-9. PubMed ID: 21158919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Posttransplant diabetes mellitus in kidney transplant recipients receiving calcineurin or mTOR inhibitor drugs.
    Araki M; Flechner SM; Ismail HR; Flechner LM; Zhou L; Derweesh IH; Goldfarb D; Modlin C; Novick AC; Faiman C
    Transplantation; 2006 Feb; 81(3):335-41. PubMed ID: 16477217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-transplant diabetes mellitus.
    Salvadori M; Bertoni E; Rosati A; Zanazzi M
    J Nephrol; 2003; 16(5):626-34. PubMed ID: 14733407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early clinical assessment of glucose metabolism in renal allograft recipients: diagnosis and prediction of post-transplant diabetes mellitus (PTDM).
    Kuypers DR; Claes K; Bammens B; Evenepoel P; Vanrenterghem Y
    Nephrol Dial Transplant; 2008 Jun; 23(6):2033-42. PubMed ID: 18174264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High impact of rejection therapy on the incidence of post-transplant diabetes mellitus after kidney transplantation.
    Schweer T; Gwinner W; Scheffner I; Schwarz A; Haller H; Blume C
    Clin Transplant; 2014 Apr; 28(4):512-9. PubMed ID: 24649873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The risk factors for diabetes mellitus after kidney transplantation.
    Razeghi E; Heydarian P; Amerian M; Pourmand G
    Saudi J Kidney Dis Transpl; 2010 Nov; 21(6):1038-43. PubMed ID: 21060170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-transplant diabetes mellitus in liver transplantation: Hangzhou experience.
    Xu X; Ling Q; He ZL; Gao F; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):465-70. PubMed ID: 18842490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study and prevalence of post-transplant diabetes mellitus; analysis on a group of kidney transplant recipients].
    Fernández Castillo R; Fernandez Gallegos R; Gomez Urquiza JL; Cañadas de la Fuente GA; Esteban de la Rosa RJ; Peña Amaro MP
    Nutr Hosp; 2014 Oct; 30(4):813-7. PubMed ID: 25335667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of tacrolimus and the development of posttransplant diabetes mellitus: a Brazilian single-center, observational study.
    Gnatta D; Keitel E; Heineck I; Cardoso BD; Rodrigues AP; Michel K; Garcia VD
    Transplant Proc; 2010 Mar; 42(2):475-8. PubMed ID: 20304169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.